JSMO Committee on Guideline Program

[GL2] JSMO Committee on Guideline Program 　About the Practical Guideline of Bone Metastasis, Revised 2nd Edition

Fri. Feb 18, 2022 9:10 AM - 9:50 AM Room 10 (Royal Room, 1F, The Prince Kyoto Takaragaike)

Chair：Hiroyuki Shibata（Department of Clinical Oncology, Graduate School of Medicine, Akita University）

+Add all to schedule

[GL2-1] Diagnosis of bone metastasis, local treatment (other than surgery)

^○Shunsuke Kato (Department of Clinical Oncology, Juntendo University Graduate School of Medicine)

[GL2-2] Importance of locomotive management -Significance of ambulant ability in patients with bone metastasis-

^○Hirotaka Kawano (Department of Orthopaedic Surgery, Teikyo University School of Medicine)

[GL2-3] Efficacy of bone modifying agents and anticancer drugs

^○Hisakazu Nishimori (Department of Hematology and Oncology, Okayama University Hospital)

[GL2-4] Safe and effective use of Bone modifying agent

^○Makoto Kodaira¹, Junya Sato^2,3, Hiroyuki Harada⁴, Haruo Iguchi⁵, Taichi Yoshida⁶, Hiroyuki Shibata⁶ (1.Department of Medical Oncology, Kodaira Hospital, 2.Department of Pharmacy, International University of Health and Welfare, 3.Faculty of Pharmacy, International University of Health and Welfare, 4.Department of Oral and Maxillofacial Surgery, Division of Oral Health Sciences, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 5.Sasebo Kyosai Hospital, 6.Department of Clinical Oncology, Akita University Graduate School of Medicine)

[GL2-5] Criteria for treatment efficacy, analgesics, RI therapy, rehabilitation, and nursing

^○Ikuo Sekine (Department of Medical Oncology, University of Tsukuba)